Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Leukemia 39Myelodysplastic Syndromes 29Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Biphenotypic, Acute 8Recurrence 7Lymphoma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Hematologic Neoplasms 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Neoplasms 3Multiple Myeloma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Juvenile 3Graft vs Host Disease 3Myelodysplastic-Myeloproliferative Diseases 2

Interventions

midostaurin 2vandetanib 1selinexor 1pegfilgrastim 1Topotecan 1Rituximab 1Prednisone 1Paclitaxel 1Methylprednisolone 1Immunologic Techniques 1Ifosfamide 1Flow Cytometry 1Etoposide 1Dexamethasone 1Clofarabine 1Carboplatin 1Bexarotene 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Aggression × Clofarabine × Clear all
NCT00201669 2017-12-06

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
6 enrolled
Lymphoid

Aggression, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡